BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 18 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | -33.3% | 1,000 | -16.0% | 0.00% | – |
Q2 2021 | $3,000 | -40.0% | 1,190 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | +66.7% | 1,190 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | -93.6% | 1,190 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $47,000 | – | 1,190 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRUE Private Wealth Advisors | 55,500 | $64,000 | 0.01% |
Aspire Private Capital, LLC | 1,600 | $2,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 4,692 | $5,000 | 0.00% |
Global Retirement Partners, LLC | 500 | $1,000 | 0.00% |
CREDIT AGRICOLE S A | 4,240 | $5,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 13,768 | $16,000 | 0.00% |
ENVESTNET ASSET MANAGEMENT INC | 163,423 | $191,000 | 0.00% |
Citadel Advisors | 23,844 | $28,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,138 | $13,000 | 0.00% |